Check out our most popular compounded medications! Get Started
This compounded formulation features a blend of estriol/estradiol (80%-20%) at 1.25-5 mg/ml and estriol/estradiol (50%-50%) at 0.5-1 mg/ml, complemented by progesterone at 50-200 mg. It is typically used for the treatment of conditions such as vaginal atrophy, menopause, uterine fibroids, endometriosis, and polycystic ovary syndrome.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This compounded formulation is a unique blend of estriol/estradiol [80%-20%] 1.25 mg/ml - 5 mg/ml in a topical gel form, and estriol/estradiol [50%/50%] 0.5-1 mg/progesterone 50-200 mg in a troche form. The troche is a square-shaped solid dosage form designed to dissolve slowly in the mouth, delivering medication through oral mucosa absorption for targeted local or systemic effects. This combination is specifically designed to treat a variety of disease states.
For menopausal symptoms such as hot flashes, night sweats, and vaginal dryness, the estriol/estradiol component of this formulation can provide significant relief.
It's important to note that the effectiveness of this formulation can vary depending on the individual's specific health needs and circumstances. Therefore, it's crucial to consult with a healthcare provider before starting any new medication regimen. If you have any questions about this formulation or how it can be used to treat these disease states, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the information and support you need.
This compounded formulation of Estriol/Estradiol [80%-20%] 1.25 mg/ml - 5 mg/ml Topical Gel and Estriol/Estradiol [50%/50%] 0.5-1 mg/Progesterone 50-200 mg Troche is designed to address a range of health conditions, including menopausal symptoms, postmenopausal osteoporosis, and as part of hormone replacement therapy. The two key components, Estriol and Estradiol, are estrogen hormones that work in tandem to alleviate menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. Estriol, being a milder form of estrogen, and Estradiol, a more potent variant, provide a balanced approach to symptom management.
Progesterone, another hormone in this formulation, serves to counterbalance the effects of estrogen, thereby helping to reduce the risk of endometrial cancer. This formulation is also beneficial in the treatment of postmenopausal osteoporosis, as it aids in increasing bone density and reducing the risk of fractures. Furthermore, it is used in hormone replacement therapy to replenish the hormones that are lost during menopause.
It is crucial to be aware that this formulation may interact with other medications, including anticoagulants, anticonvulsants, and certain antibiotics. Additionally, it may increase the risk of certain side effects, such as nausea, vomiting, breast tenderness, and headaches. More serious risks include an increased likelihood of blood clots, stroke, and heart attack.
If you have any questions or concerns about this formulation or its potential interactions, it is recommended to consult with a healthcare professional for personalized advice.
This compounded formulation combines estriol/estradiol (80%-20%) 1.25 mg/ml - 5 mg/ml in a topical gel and estriol/estradiol (50%/50%) 0.5-1 mg/progesterone 50-200 mg in a troche. It is designed to address a range of conditions including menopausal symptoms, endometriosis, and uterine fibroids.
The estriol/estradiol topical gel is applied directly to the skin, typically once or twice daily. It delivers a consistent release of hormones into the bloodstream, helping to alleviate symptoms such as hot flashes, night sweats, and vaginal dryness.
The estriol/estradiol troche is a square-shaped solid dosage form designed to dissolve slowly in the mouth. It is typically taken once or twice daily and delivers medication through oral mucosa absorption for targeted local or systemic effects. This method of delivery helps to alleviate symptoms such as irregular menstrual cycles, heavy bleeding, and pelvic pain.
The progesterone troche, also a square-shaped solid dosage form, is designed to dissolve slowly in the mouth. It is typically taken once or twice daily and delivers medication through oral mucosa absorption for targeted local or systemic effects. This method of delivery helps to alleviate symptoms associated with endometriosis and uterine fibroids.
For any questions or further information about this formulation, please do not hesitate to reach out.
This compounded formulation of Estriol/Estradiol [80%-20%] 1.25 mg/ml - 5 mg/ml Topical Gel and Estradiol/Estradiol [50%/50%] 0.5-1 mg/Progesterone 50-200 mg Troche is a versatile treatment option for a variety of conditions. It can be used to address hypoestrogenism, a condition characterized by low levels of estrogen in the body. This formulation can also be used in the treatment of breast cancer, a common type of cancer in women.
Furthermore, this formulation can be used to reduce the risk of endometrial hyperplasia in postmenopausal women who are taking conjugated estrogens. Endometrial hyperplasia is a condition that thickens the lining of the uterus and can lead to cancer. This formulation can also be used to manage symptoms of premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome that includes physical and behavioral symptoms.
Additionally, this formulation can be used to reduce the risk of endometrial cancer in women with an intact uterus who are taking conjugated estrogens. It can also be used to treat symptoms of vulvovaginal atrophy, such as vaginal dryness, itching, burning, and dyspareunia, which is painful sexual intercourse due to medical or psychological causes. If you have any questions about how this formulation can be used to treat other conditions, please consult with a healthcare professional.
This is a compounded formulation of hormones including Estriol, Estradiol, and Progesterone. The Estriol/Estradiol [80%-20%] 1.25 mg/ml - 5 mg/ml is a topical gel, while the Estriol/Estradiol [50%/50%] 0.5-1 mg/Progesterone 50-200 mg is a troche, a square-shaped solid dosage form designed to dissolve slowly in the mouth.
The troche is designed to dissolve slowly in the mouth, delivering medication through oral mucosa absorption. This allows for targeted local or systemic effects, depending on the medication and the patient's needs.
The topical gel should be applied as directed by your healthcare provider. It is typically applied to the skin, where it is absorbed into the body.
This compounded formulation allows for personalized dosing and targeted delivery of medication. It can be particularly beneficial for patients who have specific needs that are not met by standard formulations.
As with any medication, there can be side effects. These can vary depending on the individual and the specific formulation. It's important to discuss potential side effects with your healthcare provider.
This formulation is typically prescribed for specific health conditions and may not be suitable for everyone. Always consult with your healthcare provider before starting any new medication.
Store this medication as directed by your healthcare provider or pharmacist. Typically, it should be kept in a cool, dry place out of reach of children.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at the same time.
It's important to discuss all medications you're currently taking with your healthcare provider, as there can be interactions. Always consult with your healthcare provider before starting any new medication.
If you experience any adverse reactions, contact your healthcare provider immediately. If the reaction is severe, seek emergency medical attention.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Place 1 troche between cheek and gum and let slowly dissolve
